FDA Inspection 1248313 — Intra-Cellular Therapies Inc
The FDA completed an inspection of Intra-Cellular Therapies Inc on July 31, 2024 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 31, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New York, NY (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)